{"id":805,"date":"2023-10-17T20:32:34","date_gmt":"2023-10-17T20:32:34","guid":{"rendered":"https:\/\/evidencetoprac.wpenginepowered.com\/?p=805"},"modified":"2024-01-31T18:19:09","modified_gmt":"2024-01-31T18:19:09","slug":"medications-for-opioid-use-disorder-for-people-experiencing-homelessness","status":"publish","type":"post","link":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/","title":{"rendered":"Medications for Opioid Use Disorder for People Experiencing Homelessness"},"content":{"rendered":"

Background<\/span><\/h3>\n

Opioid use disorder (OUD) affects approximately <\/span>2.7 million<\/span><\/a> individuals in the US. In 2021, nearly <\/span>110,000 drug overdose deaths<\/span><\/a> occurred, <\/span>75%<\/span><\/a> were opioid-related. These numbers have only <\/span>increased<\/span><\/a> in recent years, leading the Department of Health and Human Services to renew opioid use as a national <\/span>public health emergency<\/span><\/a> in 2023. In addition to fatalities, opioid use disorder can result in adverse physical, psychological, and social <\/span>outcomes<\/span><\/a>. Research has indicated that medications for opioid use disorder (MOUD), which include methadone, buprenorphine, and naltrexone, are an <\/span>effective method<\/span><\/a> to treat OUD. However, uptake remains low, with less than <\/span>10%<\/span><\/a> of those with OUD utilizing these medications.\u00a0<\/span><\/p>\n

 <\/p>\n

While OUD consequences have been studied extensively, a gap in research remains on how to promote OUD treatment, especially in people experiencing homelessness (PEH). PEH disproportionately experience opioid overdose fatalities, facing up to a <\/span>30 times higher risk<\/span><\/a> compared to housed individuals. Understanding the factors contributing to the lack of MOUD uptake is critical when devising interventions to increase utilization. Semi-structured interviews conducted by Swartz et al. evaluated PEH with a history of opioid overdose on influences to seeking care. Researchers found that nonfatal overdoses <\/span>deterred<\/span><\/a> individuals from initiating treatment. <\/span>Reasons<\/span><\/a> included emotional distress, sickness from naloxone, and negative interactions with healthcare providers. On the other hand, the <\/span>consequences<\/span><\/a> of chronic opioid use, such as the stress of avoiding withdrawal symptoms, prompted a desire to start MOUD.<\/span> Other studies found common barriers to treatment, including <\/span>transportation<\/span><\/a>, <\/span>stigma<\/span><\/a>, and <\/span>withdrawal<\/span><\/a>.<\/span> For example, participants noted that experiencing homelessness made it difficult to endure withdrawal symptoms. When attempting to access resources to help them through this process, long waitlists, lack of insurance, and lack of transportation inhibited their <\/span>progress<\/span><\/a>.\u00a0<\/span><\/p>\n

 <\/p>\n

Gaps and Opportunities<\/span><\/h3>\n

Although these studies provide valuable insight into factors influencing MOUD use among PEH, more research is needed to fully understand the issue’s scope. Journey mapping is one way to determine common barriers to care and touchpoints with the healthcare system. Following a patient\u2019s experience can identify and address gaps in service. This data can be leveraged to tailor interventions based on unique community needs.\u00a0<\/span><\/p>\n

 <\/p>\n

Want to Learn More?<\/span><\/i><\/h3>\n

Evidence to Practice holds the expertise to document and assess a patient’s journey. Highly experienced in data collection and analyses, clients can expect quality research and a professional, collaborative partnership. Please reach out for more information.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Background Opioid use disorder (OUD) affects approximately 2.7 million individuals in the US. In 2021, nearly 110,000 drug overdose deaths […]<\/p>\n","protected":false},"author":1,"featured_media":806,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-805","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nMedications for Opioid Use Disorder for People Experiencing Homelessness - Evidence to Practice<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medications for Opioid Use Disorder for People Experiencing Homelessness - Evidence to Practice\" \/>\n<meta property=\"og:description\" content=\"Background Opioid use disorder (OUD) affects approximately 2.7 million individuals in the US. In 2021, nearly 110,000 drug overdose deaths […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/\" \/>\n<meta property=\"og:site_name\" content=\"Evidence to Practice\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-17T20:32:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-31T18:19:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/etpractice.com\/wp-content\/uploads\/2023\/10\/Blog-3-Medications-for-Opioid-Use-Disorder.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Chris\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Chris\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/\",\"url\":\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/\",\"name\":\"Medications for Opioid Use Disorder for People Experiencing Homelessness - Evidence to Practice\",\"isPartOf\":{\"@id\":\"https:\/\/etpractice.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/etpractice.com\/wp-content\/uploads\/2023\/10\/Blog-3-Medications-for-Opioid-Use-Disorder.jpg\",\"datePublished\":\"2023-10-17T20:32:34+00:00\",\"dateModified\":\"2024-01-31T18:19:09+00:00\",\"author\":{\"@id\":\"https:\/\/etpractice.com\/#\/schema\/person\/3cbd104b1f647d8e161516973234d633\"},\"breadcrumb\":{\"@id\":\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#primaryimage\",\"url\":\"https:\/\/etpractice.com\/wp-content\/uploads\/2023\/10\/Blog-3-Medications-for-Opioid-Use-Disorder.jpg\",\"contentUrl\":\"https:\/\/etpractice.com\/wp-content\/uploads\/2023\/10\/Blog-3-Medications-for-Opioid-Use-Disorder.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/etpractice.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medications for Opioid Use Disorder for People Experiencing Homelessness\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/etpractice.com\/#website\",\"url\":\"https:\/\/etpractice.com\/\",\"name\":\"Evidence to Practice\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/etpractice.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/etpractice.com\/#\/schema\/person\/3cbd104b1f647d8e161516973234d633\",\"name\":\"Chris\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/etpractice.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1ecc295d58ceecac13aac98e7bd20b55?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1ecc295d58ceecac13aac98e7bd20b55?s=96&d=mm&r=g\",\"caption\":\"Chris\"},\"sameAs\":[\"https:\/\/evidencetoprac.wpenginepowered.com\"],\"url\":\"https:\/\/etpractice.com\/author\/chris\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medications for Opioid Use Disorder for People Experiencing Homelessness - Evidence to Practice","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/","og_locale":"en_US","og_type":"article","og_title":"Medications for Opioid Use Disorder for People Experiencing Homelessness - Evidence to Practice","og_description":"Background Opioid use disorder (OUD) affects approximately 2.7 million individuals in the US. In 2021, nearly 110,000 drug overdose deaths […]","og_url":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/","og_site_name":"Evidence to Practice","article_published_time":"2023-10-17T20:32:34+00:00","article_modified_time":"2024-01-31T18:19:09+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/etpractice.com\/wp-content\/uploads\/2023\/10\/Blog-3-Medications-for-Opioid-Use-Disorder.jpg","type":"image\/jpeg"}],"author":"Chris","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Chris","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/","url":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/","name":"Medications for Opioid Use Disorder for People Experiencing Homelessness - Evidence to Practice","isPartOf":{"@id":"https:\/\/etpractice.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#primaryimage"},"image":{"@id":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#primaryimage"},"thumbnailUrl":"https:\/\/etpractice.com\/wp-content\/uploads\/2023\/10\/Blog-3-Medications-for-Opioid-Use-Disorder.jpg","datePublished":"2023-10-17T20:32:34+00:00","dateModified":"2024-01-31T18:19:09+00:00","author":{"@id":"https:\/\/etpractice.com\/#\/schema\/person\/3cbd104b1f647d8e161516973234d633"},"breadcrumb":{"@id":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#primaryimage","url":"https:\/\/etpractice.com\/wp-content\/uploads\/2023\/10\/Blog-3-Medications-for-Opioid-Use-Disorder.jpg","contentUrl":"https:\/\/etpractice.com\/wp-content\/uploads\/2023\/10\/Blog-3-Medications-for-Opioid-Use-Disorder.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/etpractice.com\/medications-for-opioid-use-disorder-for-people-experiencing-homelessness\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/etpractice.com\/"},{"@type":"ListItem","position":2,"name":"Medications for Opioid Use Disorder for People Experiencing Homelessness"}]},{"@type":"WebSite","@id":"https:\/\/etpractice.com\/#website","url":"https:\/\/etpractice.com\/","name":"Evidence to Practice","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/etpractice.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/etpractice.com\/#\/schema\/person\/3cbd104b1f647d8e161516973234d633","name":"Chris","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/etpractice.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1ecc295d58ceecac13aac98e7bd20b55?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ecc295d58ceecac13aac98e7bd20b55?s=96&d=mm&r=g","caption":"Chris"},"sameAs":["https:\/\/evidencetoprac.wpenginepowered.com"],"url":"https:\/\/etpractice.com\/author\/chris\/"}]}},"_links":{"self":[{"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/posts\/805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/comments?post=805"}],"version-history":[{"count":0,"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/posts\/805\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/media\/806"}],"wp:attachment":[{"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/media?parent=805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/categories?post=805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/etpractice.com\/wp-json\/wp\/v2\/tags?post=805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}